212 related articles for article (PubMed ID: 1722991)
21. Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation.
Olinger GN; Hussey CV; Olive JA; Malik MI
J Thorac Cardiovasc Surg; 1984 May; 87(5):673-7. PubMed ID: 6717046
[TBL] [Abstract][Full Text] [Related]
22. Heparin-induced thrombosis treated with ancrod.
Brennan MB; MacKean GL
Can J Surg; 1994 Apr; 37(2):161-4. PubMed ID: 8156472
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of iloprost (ZK36374) versus aspirin in preventing heparin-induced platelet activation during cardiac operations.
Kappa JR; Horn MK; Fisher CA; Cottrell ED; Ellison N; Addonizio VP
J Thorac Cardiovasc Surg; 1987 Sep; 94(3):405-13. PubMed ID: 2442566
[TBL] [Abstract][Full Text] [Related]
24. The heparin-induced thrombocytopenia and thrombosis syndrome: treatment with intraarterial urokinase and systemic platelet aggregation inhibitors.
Murphy KD; McCrohan G; DeMarta DA; Shirodkar NB; Kwon OJ; Chopra PS
Cardiovasc Intervent Radiol; 1996; 19(2):123-7. PubMed ID: 8662173
[TBL] [Abstract][Full Text] [Related]
25. [Heparin-induced thrombocytopenia].
Koide M; Matsuo T
Ryoikibetsu Shokogun Shirizu; 1998; (21 Pt 2):307-10. PubMed ID: 9833497
[No Abstract] [Full Text] [Related]
26. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation.
Chen HC; Chen YL; Guo BF; Tsai TH; Chang JP; Pan KL; Lin YS; Chen MC
Can J Cardiol; 2013 Sep; 29(9):1110-7. PubMed ID: 23474139
[TBL] [Abstract][Full Text] [Related]
27. Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis.
Hupkens P; Cooley BC
Microsurgery; 1996; 17(4):226-9. PubMed ID: 9140956
[TBL] [Abstract][Full Text] [Related]
28. Heparin-associated thrombocytopenia and thrombosis: optimal therapy with ancrod.
Cole CW; Fournier LM; Bormanis J
Can J Surg; 1990 Jun; 33(3):207-10. PubMed ID: 2190683
[TBL] [Abstract][Full Text] [Related]
29. Heparin-induced thrombocytopenia with thrombosis of the aorta, iliac arteries and right axillary vein successfully treated by low-molecular weight heparin.
Patrassi GM; Luzzatto G
Acta Haematol; 1994; 91(1):55-6. PubMed ID: 8171941
[No Abstract] [Full Text] [Related]
30. [Treatment of massive arterial thrombosis caused by thrombocytopenia induced by heparin with local thrombolysis].
Delagardelle C; Harf C; Dondelinger RF; Goffette P; Beissel J; Pesch C; Welter R
Arch Mal Coeur Vaiss; 1990 Jan; 83(1):113-5. PubMed ID: 2106299
[TBL] [Abstract][Full Text] [Related]
31. Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome.
Almeida JI; Coats R; Liem TK; Silver D
J Vasc Surg; 1998 Feb; 27(2):309-14; discussion 315-6. PubMed ID: 9510285
[TBL] [Abstract][Full Text] [Related]
32. Are agents affecting platelet functions clinically useful?
Verstraete M
Am J Med; 1976 Dec; 61(6):897-914. PubMed ID: 795299
[TBL] [Abstract][Full Text] [Related]
33. Heparin-induced thrombocytopenia and thromboembolism in the postoperative period.
Rizzoni WE; Miller K; Rick M; Lotze MT
Surgery; 1988 Apr; 103(4):470-6. PubMed ID: 3353858
[TBL] [Abstract][Full Text] [Related]
34. [Comparative study of 2 antithrombotic regimens in 75 patients with coronary endoprostheses].
Iturbe T; Sánchez C; Moreno JA; Olave T; Azaceta G; Varo MJ; Civeira E; Peleato J; Cornudella R
Sangre (Barc); 1997 Oct; 42(5):387-90. PubMed ID: 9424739
[TBL] [Abstract][Full Text] [Related]
35. [Thrombocytopenia associated with massive cardiac thrombosis during treatment with non-fractionated heparin: description of a clinical case].
De Piccoli B; Martino A; Zuin G; Raviele A
Ital Heart J Suppl; 2002 Aug; 3(8):869-73. PubMed ID: 12407843
[TBL] [Abstract][Full Text] [Related]
36. Heparin-induced immune thrombocytopenia.
Babcock RB; Dumper CW; Scharfman WB
N Engl J Med; 1976 Jul; 295(5):237-41. PubMed ID: 945459
[TBL] [Abstract][Full Text] [Related]
37. The white clot syndrome or heparin associated thrombocytopenia and thrombosis (WCS or HATT) (26 cases).
Benhamou AC; Gruel Y; Barsotti J; Castellani L; Marchand M; Guerois C; Leclerc MH; Delahousse B; Griguer P; Leroy J
Int Angiol; 1985; 4(3):303-10. PubMed ID: 3831153
[TBL] [Abstract][Full Text] [Related]
38. Heparin-induced thrombocytopenia and thrombosis: presentation after cardiopulmonary bypass.
Munver R; Schulman IC; Wolf DJ; Rosengart TK
Ann Thorac Surg; 1994 Dec; 58(6):1764-6. PubMed ID: 7979757
[TBL] [Abstract][Full Text] [Related]
39. [Various therapy options. Medical Chemistry of platelet aggregation inhibitors].
Zettl H; Schubert-Zsilavecz M
Pharm Unserer Zeit; 2009; 38(4):314-9. PubMed ID: 19572349
[No Abstract] [Full Text] [Related]
40. Heparin-induced platelet activation: the role of thromboxane A2 synthesis and the extent of platelet granule release in two patients.
Kappa JR; Fisher CA; Addonizio VP
J Vasc Surg; 1989 Apr; 9(4):574-9. PubMed ID: 2709525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
